dr. tripathy on the use of tamoxifen in hormone receptor-positive breast cancers
Published 11 years ago • 424 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
1:22
dr. tripathy on augmenting the benefit of hormonal therapy in breast cancer
-
1:20
dr. tripathy on 10 versus 5 years of aromatase inhibitors
-
1:25
dr. debu tripathy on 10 versus 5 years of adjuvant tamoxifen
-
1:19
debu tripathy on hormonal therapy for breast cancer
-
1:50
dr. tripathy on the management of hr early-stage breast cancer
-
2:13
dr. tripathy on frontline endocrine therapies in hr breast cancer
-
2:22
dr. tripathy on the treatment of breast cancer with anthracyclines and trastuzumab
-
1:55
role of next-generation sequencing in neuroendocrine tumors (nets)
-
0:23
copy of dr. tripathy on the management of hr early-stage breast cancer
-
2:24
dr. tripathy on genomically guided therapy in breast cancer
-
1:23
dr. tripathy discusses breast cancer prevention
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
1:05
dr. tripathy on markers of resistance in breast cancer
-
1:47
dr. tripathy on combination strategies with cdk4/6 inhibitors in breast cancer
-
1:09
dr. debu tripathy on molecular predictors of outcome in breast cancer
-
0:45
dr. tripathy discusses breast cancer gene profiling
-
0:54
dr. tripathy on the treatment of patients with metastatic breast cancer
-
2:39
dr. tripathy on integrative oncology
-
0:27
how to cope with tamoxifen and letrozole